Develops experimental in vivo CAR-T therapies
Shanghai, ChinaBiotech
2 sources · checked 2 times, last 1h ago
TechStartups reports approximately RMB 100 million; VCBeat’s specific round report states RMB 100 million, which is preferred. No source states a lead investor, valuation, financing total, or headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-A Pre-Series A | $15.0M ~RMB 200M reported financing total approximately RMB 100 million | 2026-10-26 | not stated | 1 person on X · 2 outlets. #17 in Trending |
2 sources · checked 2 times, last 1h ago [ VERIFIED · CORRECTED ] read against 2 sources
TechStartups reports approximately RMB 100 million; VCBeat’s specific round report states RMB 100 million, which is preferred. No source states a lead investor, valuation, financing total, or headquarters. [ BUILT WITH ]·[ SEARCH ]found on a watched publisher·[ SCRAPE ]2 pages read: techstartups.com, vcbeathealth.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ ]posts from 1 person, found with Firecrawl search | ||||
1 person on 2 outlets
Found on X with Firecrawl search